Creative Commons Licensing Information
BHJ embeds machine-readable CC licensing information in its article metadata.

All Published PDF's will carry this information: (PROVIDED BELOW IS A SAMPLE TEXT)

Copyright © 2019 BHJ, Open Access Journal. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit

Permissions/ Conflict of interest policy /Copyright
Incessant Nature Science (INS) Publishers journals group has a transparent publications policy and adheres in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). INS Journals  does not discriminate on the basis of the source of material submitted, provided full disclosure is provided and appropriate declaration of interest statements and acknowledgments are included in published manuscripts. Thus, we require that authors/submitters include comprehensive ‘Declaration of Interest’ and ‘Acknowledgements’ sections in submitted articles. All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

More specifically, we request for the following:
  • All relevant potential conflicts of interest for each named author and/or a statement of no- conflicts if there are none relevant to the contents of the article for any author(s).
  • Disclosure of how the article is funded, and specifically, the disclosure of any and all pharmaceutical company funding (partial or total) OR a statement that there was no involvement of a pharmaceutical/other company (if this is the case).
  • Comprehensive explanation of the role of the sponsors in article preparation (if the article is sponsored in part or whole).
  • Disclosure of any medical writing/editorial assistance with the preparation of the article (the medical communication agency and the individuals involved need to be named).
INS Journals also strictly requires that all individuals who meet authorship criteria as per ICMJE requirements are included as authors on an article.

Contributions from individuals who do not qualify for authorship should be acknowledged in the ‘Acknowledgments’ section. This should include details (with professional affiliations) of any other contributorship, such as data analysis, statistics, data collection, technical assistance, special thanks, personal assistance, and dedications.

The ‘Declaration of Interest’ and ‘Acknowledgements’ sections will be made available to reviewers and will appear in the published article. Please note that the Editor(s) or Publisher can make or suggest changes to these statements where necessary. If any potential conflicts of interest are found to have been withheld following publication, the journal will proceed according to the Committee on Publication Ethics (COPE) guidance.

The intent of this policy is not to prevent authors with any particular relationship or interest from publishing their work, but rather to adopt transparency such that reviewers, editors, the publisher, and most importantly, readers can make objective judgements concerning the work product.

Once published, the article will be made free to read and reuse upon publication under a Creative Commons Attribution (CC-BY NC) license 4.0

The published article can be distributed under the terms of the Creative Common Attribution License (CC BY NC). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms